Lael M Yonker
Overview
Explore the profile of Lael M Yonker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
117
Citations
2509
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goetzke C, Massoud M, Frischbutter S, Guerra G, Ferreira-Gomes M, Heinrich F, et al.
Nature
. 2025 Mar;
PMID: 40074901
In a subset of children and adolescents, SARS-CoV-2 infection induces a severe acute hyperinflammatory shock termed multisystem inflammatory syndrome in children (MIS-C) at four to eight weeks after infection. MIS-C...
2.
Proal A, Aleman S, Bomsel M, Brodin P, Buggert M, Cherry S, et al.
Lancet Infect Dis
. 2025 Feb;
PMID: 39947217
There are no approved treatments for post-COVID-19 condition (also known as long COVID), a debilitating disease state following SARS-CoV-2 infection that is estimated to affect tens of millions of people....
3.
Nazemidashtarjandi S, Supple M, Yonker L, Sheridan R, Ryan C, Karabacak M, et al.
FASEB J
. 2025 Jan;
39(2):e70336.
PMID: 39853997
Circulating monocytes contribute to the defense against pathogens and play a crucial role in maintaining immune homeostasis. While there is substantial evidence regarding the triggers of monocyte activation, our understanding...
4.
Liu V, Godfrey M, Dunn M, Fowler R, Guthrie L, Dredge D, et al.
Front Pediatr
. 2025 Jan;
12():1484941.
PMID: 39764158
Introduction: Given the challenges in diagnosing children with long COVID, we sought to explore diagnostic practices and preferences among clinicians. Methods: A ten-question survey assessed pediatric providers' clinical decision making...
5.
Keating C, Yonker L, Vermeulen F, Prais D, Linnemann R, Trimble A, et al.
Lancet Respir Med
. 2025 Jan;
13(3):256-271.
PMID: 39756424
Background: The goal of cystic fibrosis transmembrane conductance regulator (CFTR) modulators is to reach normal CFTR function in people with cystic fibrosis. Vanzacaftor-tezacaftor-deutivacaftor restored CFTR function in vitro and in...
6.
Yonker L, Badaki-Makun O, Alvarez-Carcamo B, Cross C, Okuducu Y, Appleman L, et al.
Shock
. 2025 Jan;
63(3):385-389.
PMID: 39749928
Background: Early, accurate determination of disease severity in an emergency setting is paramount for improving patient outcomes and healthcare costs. Monocyte anisocytosis, quantified as monocyte distribution width (MDW), has been...
7.
Jasset O, Lopez Zapana P, Bahadir Z, Shook L, Dennis M, Gilbert E, et al.
Am J Obstet Gynecol
. 2024 Nov;
PMID: 39515450
Background: Respiratory syncytial virus is associated with significant neonatal and infant morbidity and mortality. Maternal bivalent respiratory syncytial virus prefusion F respiratory syncytial virus vaccination to protect neonates and infants...
8.
Papadakis L, Stander T, Mombourquette J, Richards C, Yonker L, Lawton B, et al.
Pediatr Pulmonol
. 2024 Nov;
60(1):e27382.
PMID: 39503182
Background: The benefits of Elexecaftor-Tezacaftor-Ivacaftor (ETI) therapy on the health and wellbeing of people with CF (pwCF) are well documented. Since approval, however, a growing number of potential side effects...
9.
Buonsenso D, Yonker L
Lancet Reg Health Eur
. 2024 Nov;
46():101109.
PMID: 39493249
No abstract available.
10.
Tang Y, Boribong B, Swank Z, Demokritou M, Luban M, Fasano A, et al.
J Infect Dis
. 2024 Sep;
230(6):1390-1399.
PMID: 39253950
Background: Understanding antibody responses to SARS-CoV-2 vaccination is crucial for refining COVID-19 immunization strategies. Generation of mucosal immune responses, including mucosal IgA, could be of potential benefit to vaccine efficacy;...